Rank | Title of the publication/first author/publishing year/publishing journal | Annual citations |
---|---|---|
1 | Zoledronic acid and clinical fractures and mortality after hip fracture/Lyles/2007/The New England Journal of Medicine | 75.5 |
2 | Effect of risedronate on the risk of hip fracture in elderly women/McClung/2001/The New England Journal of Medicine | 66.05 |
3 | A systematic review of hip fracture incidence and probability of fracture worldwide/Kanis/2012/Osteoporosis International | 58.89 |
4 | Incidence and Mortality of Hip fractures in the United States/Braur/2009/The Journal of the American Medical Association | 57.92 |
5 | Meta-analysis: Excess Mortality After Hip fracture Among Older Women and Men/Patrick/2010/Annals of Internal Medicine | 54.55 |
6 | Predictive value of BMD for hip and other fractures/Olof/2005/Journal of Bone and Mineral Research | 54.13 |
7 | Long-term proton pump inhibitor therapy and risk of hip fracture/Yang/2006/The Journal of the American Medical Association | 49.67 |
8 | The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women/Kanis/2007/Osteoporosis International | 49.29 |
9 | Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study/Roche/2005/British Medical Journal | 41.13 |
10 | Secular trends in the incidence of hip and other osteoporotic fractures/Cooper/2011/Osteoporosis International | 41.1 |